CN
|
EN
Home
Introduction to the 2022 CBIIC
Main Conference
Previous Speakers
News
Organizations
Service
Transportation & Accommodation
Guidance
Contact us
Previous Review
Home
About CBIIC
Previous Speakers
News
Expert
Organizations
Service
Transportation & Accommodation
Guidance
Contact us
Previous Review
Register
Roadshow Application
Roadshow Center)
CN
EN
Non-Listed Company Roadshow
Schedule
Profile details
13:30 PM-17:40 PM
Moderator
杨烨辉, 国联证券医药行业负责人/所长助理
YANG Yehui, Head of Medical Industry/ Assistant Director, Guolian Securities
13:30 PM-14:00 PM
开场报告
Keynote Speech
创新药企业投融资的趋势和展望
The Investment Trend and Prospect of Innovative Drug Enterprises
杨烨辉,国联证券医药行业负责人/所长助理
YANG Yehui,Head of Medical Industry/ Assistant Director, Guolian Securities
14:00 PM-14:20 PM
项目1
Project 1
亚洲干细胞
TM
干细胞药物研发、注册申报及转化应用
Stem Cell Drug Research, Development, Registration, Application and Transformation Application
齐念民,上海泉生生物科技有限公司董事长
QI Nianmin, Chairman, Asia Stem Cell Regenerative Pharmaceutical Co., Ltd.
14:20 PM-14:40 PM
项目2
Project 2
针对呼吸系统及相关疾病的FIC小分子原创新药研发
R&D of FIC Small Molecue Drugs for Respiratory System and Related Disease
程云锋, 杭州维坦医药科技有限公司创始人&首席执行官
Jerry CHENG,Founder & CEO, Hangzhou Westan PharmTech Co., Ltd.
14:40 PM-15:00 PM
项目3
Project 3
下一代CDK抑制剂:高选择性CDK7抑制剂的研发
Next Generation CDK Inhibitors: Development of A Highly Selective CDK7 Inhibitor
李铭曦, 上海湃隆生物科技有限公司总裁
LI Mingxi,President, GT Apeiron Therapeutics
15:00 PM-15:20 PM
项目4
Project 4
治疗阿尔兹海默症的新概念、新机制、新结构的小分子化合物50561
A Novel First in Concept Small Molecular 50561 for Treatment of Alzheimer's Disease
马伟伟, 北京卓凯生物技术有限公司总经理
MA Weiwei,General Manager, Beijing Joekai Biotechnology Co., Ltd.
15:20 PM-15:40 PM
项目5
Project 5
一种可协同调动NK、DC、T细胞的全新的肿瘤免疫疗法
A New Immunotherapy Which Can Harness NK, DC and T Cells Synergistically
杜小波, 重庆勉弈生物技术有限公司联合创始人
DU Xiaobo,Cofounder, Chongqing mianyi Biotechnology Co., Ltd.
15:40 PM-16:00 PM
项目6
Project 6
澳宗生物:CNS药物研发拓荒者
Auzone: Pioneer of Central Nervous System (CNS) Drugs
周意, 苏州澳宗生物科技有限公司总经理/首席执行官
ZHOU Yi, General Manager/CEO, Suzhou Auzone Biological Technology Co., Ltd.
16:00 PM-16:20 PM
项目7
Project 7
新型干眼症药物
New Drug for Dry Eye Disease
王正旺, 北京海洁海斯健康科技有限公司总经理
DAVID WANG,G.M, BEIJING H&H
16:20 PM-16:40 PM
项目8
Project 8
一种治疗脊髓性肌萎缩症(SMA)的创新药物候选物
An Innovative Drug Candidate for the Treatment of Spinal Muscular Atrophy (SMA)
李季男, 深圳瑞健同壹生物技术有限公司首席科学家
LI Jinan, CSO, Shenzhen Ruijian Tongyi biotech company Co., Ltd.
16:40 PM-17:00 PM
项目9
Project 9
靶向离子通道治疗纤维肌痛的无成瘾性创新药物研发
The Development of Non-Addictive Drug for the Treatment of FibromyAlgia by Targeting Ion Channels
丁强, 上海璃道医药科技有限公司副总经理(生物药理总监)
DING Qiang, Vice-general manager (Director of Biological Pharmacology), Shanghai Leado Pharmatech Co., Ltd.
17:00 PM-17:20 PM
项目10
Project 10
改良型制剂LH1037的项目介绍
Introduction of the optimized formulation LH1037
丁栋, 江苏领航生物科技有限公司药理总监
DING Dong, Director of Pharmacology Department, Jiangsu Linghang Bio-technology Co., Ltd.
17:20 PM-17:40 PM
项目11
Project 11
用于治疗消化道癌的CDH17/CD3双特异性抗体新药和mRNA非病毒CDH17 CAR-NK/T治疗方法的研发和产业化(商业化)
Development and Industrialization (Commercialization) of New CDH17/CD3 Bispecific Antibody (BsAb) Drug and mRNA non-viral CDH17 CAR-NK/T Therapy for the Gastrointestinal Cancer
陆满晴, 艾贝乐医药科技有限公司首席执行官
John LUK, CEO, Arbele Limited
Specification:
Released:
September 17, 2020
Last update:
September 19, 2020
Version:
1.1
010-58156160
Contact US